Rg3 acts as a cancer suppressor by regulating VEGF-dependent tumor angiogenesis, while the long-term circulation of iron-based NpRg3 could have a therapeutic effect on circulating tumor cells by activating immune cells in the blood. Here, VEGFA is linked to cancer.